{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T21:47:30Z","timestamp":1773784050585,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s40744-025-00819-w","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T16:43:24Z","timestamp":1767717804000},"page":"313-327","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of Ixekizumab in Chinese Patients with Radiographic-Axial Spondyloarthritis by Baseline Inflammation Status on Magnetic Resonance Imaging"],"prefix":"10.1007","volume":"13","clinical-trial-number":[{"clinical-trial-number":"nct04285229","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Xiaoxia","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiankang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongzhou","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaxiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lie","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyu","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengyu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongfu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingli","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6534-3659","authenticated-orcid":false,"given":"Hongying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hejian","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"issue":"12","key":"819_CR1","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1136\/annrheumdis-2021-221035","volume":"80","author":"V Navarro-Comp\u00e1n","year":"2021","unstructured":"Navarro-Comp\u00e1n V, Sepriano A, El-Zorkany B, van der Heijde D. Axial spondyloarthritis. Ann Rheum Dis. 2021;80(12):1511\u201321. https:\/\/doi.org\/10.1136\/annrheumdis-2021-221035.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"819_CR2","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/rhu.0000000000000589","volume":"23","author":"V Strand","year":"2017","unstructured":"Strand V, Singh JA. Patient burden of axial spondyloarthritis. J Clin Rheumatol. 2017;23(7):383\u201391. https:\/\/doi.org\/10.1097\/rhu.0000000000000589.","journal-title":"J Clin Rheumatol"},{"issue":"1","key":"819_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/ard-2022-223296","volume":"82","author":"S Ramiro","year":"2023","unstructured":"Ramiro S, Nikiphorou E, Sepriano A, Ortolan A, Webers C, Baraliakos X, et al. ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis. 2023;82(1):19\u201334. https:\/\/doi.org\/10.1136\/ard-2022-223296.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"819_CR4","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/1756-185x.13510","volume":"22","author":"LS Tam","year":"2019","unstructured":"Tam LS, Wei JC, Aggarwal A, Baek HJ, Cheung PP, Chiowchanwisawakit P, et al. 2018 APLAR axial spondyloarthritis treatment recommendations. Int J Rheum Dis. 2019;22(3):340\u201356. https:\/\/doi.org\/10.1111\/1756-185x.13510.","journal-title":"Int J Rheum Dis"},{"issue":"10","key":"819_CR5","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1002\/art.41042","volume":"71","author":"MM Ward","year":"2019","unstructured":"Ward MM, Deodhar A, Gensler LS, Dubreuil M, Yu D, Khan MA, et al. 2019 update of the American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Rheumatol. 2019;71(10):1599\u2013613. https:\/\/doi.org\/10.1002\/art.41042.","journal-title":"Arthritis Rheumatol"},{"issue":"10163","key":"819_CR6","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1016\/s0140-6736(18)31946-9","volume":"392","author":"D van der Heijde","year":"2018","unstructured":"van der Heijde D, Cheng-Chung Wei J, Dougados M, Mease P, Deodhar A, Maksymowych WP, et al. Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial. Lancet. 2018;392(10163):2441\u201351. https:\/\/doi.org\/10.1016\/s0140-6736(18)31946-9.","journal-title":"Lancet"},{"issue":"4","key":"819_CR7","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/art.40753","volume":"71","author":"A Deodhar","year":"2019","unstructured":"Deodhar A, Poddubnyy D, Pacheco-Tena C, Salvarani C, Lespessailles E, Rahman P, et al. Efficacy and Safety of ixekizumab in the treatment of radiographic axial spondyloarthritis: sixteen-week results from a phase III randomized, double-blind, placebo-controlled trial in patients with prior inadequate response to or intolerance of tumor necrosis factor inhibitors. Arthritis Rheumatol. 2019;71(4):599\u2013611. https:\/\/doi.org\/10.1002\/art.40753.","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"819_CR8","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1136\/annrheumdis-2019-216118","volume":"79","author":"M Dougados","year":"2020","unstructured":"Dougados M, Wei JC, Landew\u00e9 R, Sieper J, Baraliakos X, Van den Bosch F, et al. Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W). Ann Rheum Dis. 2020;79(2):176\u201385. https:\/\/doi.org\/10.1136\/annrheumdis-2019-216118.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"819_CR9","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s40744-019-0165-3","volume":"6","author":"P Mease","year":"2019","unstructured":"Mease P, Walsh JA, Baraliakos X, Inman R, de Vlam K, Wei JC, et al. Translating improvements with ixekizumab in clinical trial outcomes into clinical practice: ASAS40, pain, fatigue, and sleep in ankylosing spondylitis. Rheumatol Ther. 2019;6(3):435\u201350. https:\/\/doi.org\/10.1007\/s40744-019-0165-3.","journal-title":"Rheumatol Ther"},{"issue":"2","key":"819_CR10","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3899\/jrheum.200093","volume":"48","author":"U Kiltz","year":"2021","unstructured":"Kiltz U, Wei JC, van der Heijde D, van den Bosch F, Walsh JA, Boonen A, et al. Ixekizumab improves functioning and health in the treatment of radiographic axial spondyloarthritis: week 52 results from 2 pivotal studies. J Rheumatol. 2021;48(2):188\u201397. https:\/\/doi.org\/10.3899\/jrheum.200093.","journal-title":"J Rheumatol"},{"issue":"1","key":"819_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s41927-021-00205-3","volume":"5","author":"AA Deodhar","year":"2021","unstructured":"Deodhar AA, Mease PJ, Rahman P, Navarro-Comp\u00e1n V, Strand V, Hunter T, et al. Ixekizumab improves spinal pain, function, fatigue, stiffness, and sleep in radiographic axial spondyloarthritis: COAST-V\/W 52-week results. BMC Rheumatol. 2021;5(1):35. https:\/\/doi.org\/10.1186\/s41927-021-00205-3.","journal-title":"BMC Rheumatol"},{"issue":"9","key":"819_CR12","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1136\/ard.2007.073098","volume":"67","author":"M Rudwaleit","year":"2008","unstructured":"Rudwaleit M, Schwarzlose S, Hilgert ES, Listing J, Braun J, Sieper J. MRI in predicting a major clinical response to anti-tumour necrosis factor treatment in ankylosing spondylitis. Ann Rheum Dis. 2008;67(9):1276\u201381. https:\/\/doi.org\/10.1136\/ard.2007.073098.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"819_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2014-000017","volume":"1","author":"JR Maneiro","year":"2015","unstructured":"Maneiro JR, Souto A, Salgado E, Mera A, Gomez-Reino JJ. Predictors of response to TNF antagonists in patients with ankylosing spondylitis and psoriatic arthritis: systematic review and meta-analysis. RMD Open. 2015;1(1):e000017. https:\/\/doi.org\/10.1136\/rmdopen-2014-000017.","journal-title":"RMD Open"},{"key":"819_CR14","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s40744-025-00765-7","volume":"12","author":"N Kong","year":"2025","unstructured":"Kong N, Hu J, Liu D, Li J, Wu H, Sun L, et al. Efficacy of ixekizumab in Chinese patients with radiographic axial spondyloarthritis by baseline C-reactive protein level. Rheumatol Ther. 2025;12:627\u201339. https:\/\/doi.org\/10.1007\/s40744-025-00765-7.","journal-title":"Rheumatol Ther"},{"issue":"11","key":"819_CR15","doi-asserted-by":"publisher","first-page":"4324","DOI":"10.1093\/rheumatology\/keac104","volume":"61","author":"WP Maksymowych","year":"2022","unstructured":"Maksymowych WP, Bolce R, Gallo G, Seem E, Geneus VJ, Sandoval DM, et al. Ixekizumab in radiographic axial spondyloarthritis with and without elevated C-reactive protein or positive magnetic resonance imaging. Rheumatology (Oxford). 2022;61(11):4324\u201334. https:\/\/doi.org\/10.1093\/rheumatology\/keac104.","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"819_CR16","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s11926-022-01079-1","volume":"24","author":"S Zhang","year":"2022","unstructured":"Zhang S, Peng L, Li Q, Zhao J, Xu D, Zhao J, et al. Spectrum of spondyloarthritis among Chinese populations. Curr Rheumatol Rep. 2022;24(8):247\u201358. https:\/\/doi.org\/10.1007\/s11926-022-01079-1.","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"819_CR17","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s40259-023-00625-2","volume":"38","author":"Y Xue","year":"2024","unstructured":"Xue Y, Hu J, Liu D, Li J, Wu H, Tan C, et al. Ixekizumab for active radiographic axial spondyloarthritis in Chinese patients: 16- and 52-week results from a phase III, randomized, double-blind, placebo-controlled study. BioDrugs. 2024;38(1):145\u201356. https:\/\/doi.org\/10.1007\/s40259-023-00625-2.","journal-title":"BioDrugs"},{"issue":"4","key":"819_CR18","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s40744-024-00688-9","volume":"11","author":"X Zhu","year":"2024","unstructured":"Zhu X, Hu J, Liu D, Li J, Wu H, Sun L, et al. Rapid and sustained effect of ixekizumab on patient global, spinal pain, stiffness, and fatigue in Chinese patients with radiographic axial spondyloarthritis. Rheumatol Ther. 2024;11(4):1011\u201322. https:\/\/doi.org\/10.1007\/s40744-024-00688-9.","journal-title":"Rheumatol Ther"},{"issue":"3","key":"819_CR19","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/art.38283","volume":"66","author":"D van der Heijde","year":"2014","unstructured":"van der Heijde D, Sieper J, Maksymowych WP, Brown MA, Lambert RG, Rathmann SS, et al. Spinal inflammation in the absence of sacroiliac joint inflammation on magnetic resonance imaging in patients with active nonradiographic axial spondyloarthritis. Arthritis Rheumatol. 2014;66(3):667\u201373. https:\/\/doi.org\/10.1002\/art.38283.","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"819_CR20","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.3899\/jrheum.140806","volume":"42","author":"R van den Berg","year":"2015","unstructured":"van den Berg R, de Hooge M, Bakker PA, van Gaalen F, Navarro-Comp\u00e1n V, Fagerli KM, et al. Metric properties of the SPARCC score of the sacroiliac joints\u2014data from baseline, 3-month, and 12-month followup in the SPACE cohort. J Rheumatol. 2015;42(7):1186\u201393. https:\/\/doi.org\/10.3899\/jrheum.140806.","journal-title":"J Rheumatol"},{"issue":"3","key":"819_CR21","doi-asserted-by":"publisher","first-page":"718","DOI":"10.55563\/clinexprheumatol\/ljpqqe","volume":"41","author":"VI Mazurov","year":"2023","unstructured":"Mazurov VI, Dubinina TV, Erdes S, Lapshina SA, Soroka NF, Kunder EV, et al. Response to netakimab in radiographic axial spondyloarthritis patients with different baseline C-reactive protein, sacroiliitis evaluated by MRI and peripheral joint involvement status: a post-hoc analysis of the ASTERA study. Clin Exp Rheumatol. 2023;41(3):718\u201326. https:\/\/doi.org\/10.55563\/clinexprheumatol\/ljpqqe.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"819_CR22","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s13075-021-02613-9","volume":"23","author":"J Braun","year":"2021","unstructured":"Braun J, Blanco R, Marzo-Ortega H, Gensler LS, van den Bosch F, Hall S, et al. Secukinumab in non-radiographic axial spondyloarthritis: subgroup analysis based on key baseline characteristics from a randomized phase III study, PREVENT. Arthritis Res Ther. 2021;23(1):231. https:\/\/doi.org\/10.1186\/s13075-021-02613-9.","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"819_CR23","doi-asserted-by":"publisher","first-page":"4125","DOI":"10.1002\/art.37695","volume":"64","author":"F Richter","year":"2012","unstructured":"Richter F, Natura G, Ebbinghaus M, von Banchet GS, Hensellek S, K\u00f6nig C, et al. Interleukin-17 sensitizes joint nociceptors to mechanical stimuli and contributes to arthritic pain through neuronal interleukin-17 receptors in rodents. Arthritis Rheum. 2012;64(12):4125\u201334. https:\/\/doi.org\/10.1002\/art.37695.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"819_CR24","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s40744-024-00660-7","volume":"11","author":"K de Vlam","year":"2024","unstructured":"de Vlam K, Maksymowych WP, Gallo G, Rahman P, Mease P, Krishnan V, et al. Exploring the effects of ixekizumab on pain in patients with ankylosing spondylitis based on objective measures of inflammation: post hoc analysis from a large randomized clinical trial. Rheumatol Ther. 2024;11(3):691\u2013707. https:\/\/doi.org\/10.1007\/s40744-024-00660-7.","journal-title":"Rheumatol Ther"},{"issue":"7","key":"819_CR25","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1002\/art.40475","volume":"70","author":"J de Winter","year":"2018","unstructured":"de Winter J, de Hooge M, van de Sande M, de Jong H, van Hoeven L, de Koning A, et al. Magnetic resonance imaging of the sacroiliac joints indicating sacroiliitis according to the assessment of SpondyloArthritis International Society definition in healthy individuals, runners, and women with postpartum back pain. Arthritis Rheumatol. 2018;70(7):1042\u20138. https:\/\/doi.org\/10.1002\/art.40475.","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"819_CR26","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1002\/art.40429","volume":"70","author":"U Weber","year":"2018","unstructured":"Weber U, Jurik AG, Zejden A, Larsen E, J\u00f8rgensen SH, Rufibach K, et al. Frequency and anatomic distribution of magnetic resonance imaging features in the sacroiliac joints of young athletes: exploring \u201cbackground noise\u201d toward a data-driven definition of sacroiliitis in early spondyloarthritis. Arthritis Rheumatol. 2018;70(5):736\u201345. https:\/\/doi.org\/10.1002\/art.40429.","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"819_CR27","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1093\/rheumatology\/kex491","volume":"57","author":"G Varkas","year":"2018","unstructured":"Varkas G, de Hooge M, Renson T, De Mits S, Carron P, Jacques P, et al. Effect of mechanical stress on magnetic resonance imaging of the sacroiliac joints: assessment of military recruits by magnetic resonance imaging study. Rheumatology (Oxford). 2018;57(3):508\u201313. https:\/\/doi.org\/10.1093\/rheumatology\/kex491.","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"819_CR28","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/acr2.11707","volume":"6","author":"RM Kiil","year":"2024","unstructured":"Kiil RM, Weber U, Jurik AG. Magnetic resonance imaging topography of bone marrow edema in the sacroiliac joint of postpartum women. ACR Open Rheumatol. 2024;6(9):561\u20137. https:\/\/doi.org\/10.1002\/acr2.11707.","journal-title":"ACR Open Rheumatol"}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-025-00819-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40744-025-00819-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-025-00819-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T18:05:59Z","timestamp":1773770759000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40744-025-00819-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["819"],"URL":"https:\/\/doi.org\/10.1007\/s40744-025-00819-w","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"value":"2198-6576","type":"print"},{"value":"2198-6584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]},"assertion":[{"value":"9 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Yan Yan and Hongying Li are employees of Eli Lilly and Company. Xiaoxia Zhu, Jiankang Hu, Dongzhou Liu, Jingyang Li, Huaxiang Wu, Lingyun Sun, Lie Dai, Chunyu Tan, Zhijun Li, Zhengyu Xiao, Yongfu Wang, Lingli Dong, and Hejian Zou have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was approved by local ethics committees (see Supplementary Table\n                      \n                      ) and conducted in accordance with the Declaration of Helsinki and the Council of International Organizations of Medical Sciences International Ethical Guidelines. Written informed consent was collected from all patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}